chrX-150660393-A-G

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 4P and 5B. PM1PM5BP6BS2

The NM_000252.3(MTM1):​c.1376A>G​(p.Asn459Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000184 in 1,194,034 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N459I) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000018 ( 0 hom. 5 hem. )

Consequence

MTM1
NM_000252.3 missense

Scores

5
7
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 8.90

Publications

2 publications found
Variant links:
Genes affected
MTM1 (HGNC:7448): (myotubularin 1) This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
MTM1 Gene-Disease associations (from GenCC):
  • X-linked myotubular myopathy
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_000252.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-150660393-A-T is described in ClinVar as Pathogenic. ClinVar VariationId is 158927.Status of the report is criteria_provided_single_submitter, 1 stars.
BP6
Variant X-150660393-A-G is Benign according to our data. Variant chrX-150660393-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 744143.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTM1NM_000252.3 linkc.1376A>G p.Asn459Ser missense_variant Exon 13 of 15 ENST00000370396.7 NP_000243.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTM1ENST00000370396.7 linkc.1376A>G p.Asn459Ser missense_variant Exon 13 of 15 1 NM_000252.3 ENSP00000359423.3

Frequencies

GnomAD3 genomes
AF:
0.0000178
AC:
2
AN:
112166
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000279
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000548
AC:
10
AN:
182415
AF XY:
0.0000596
show subpopulations
Gnomad AFR exome
AF:
0.0000763
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000361
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.0000185
AC:
20
AN:
1081818
Hom.:
0
Cov.:
27
AF XY:
0.0000143
AC XY:
5
AN XY:
349724
show subpopulations
African (AFR)
AF:
0.0000383
AC:
1
AN:
26089
American (AMR)
AF:
0.00
AC:
0
AN:
35175
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19277
East Asian (EAS)
AF:
0.000166
AC:
5
AN:
30125
South Asian (SAS)
AF:
0.0000931
AC:
5
AN:
53730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40341
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4099
European-Non Finnish (NFE)
AF:
0.0000109
AC:
9
AN:
827429
Other (OTH)
AF:
0.00
AC:
0
AN:
45553
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000178
AC:
2
AN:
112216
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34404
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30918
American (AMR)
AF:
0.00
AC:
0
AN:
10573
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.000279
AC:
1
AN:
3579
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6070
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53279
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Severe X-linked myotubular myopathy Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Jul 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1376A>G (p.N459S) alteration is located in exon 13 (coding exon 12) of the MTM1 gene. This alteration results from a A to G substitution at nucleotide position 1376, causing the asparagine (N) at amino acid position 459 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

not provided Uncertain:1
Jun 26, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.91
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.96
D
MetaRNN
Uncertain
0.68
D
MetaSVM
Uncertain
0.73
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
8.9
PrimateAI
Uncertain
0.53
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0040
D
Sift4G
Benign
0.074
T
Vest4
0.36
ClinPred
0.47
T
GERP RS
5.6
Varity_R
0.78
gMVP
0.88
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587783785; hg19: chrX-149828866; API